Prof. Marcello D'amelio
Professore Ordinario Nuovo regime
Professore Ordinario di Fisiologia Umana. Dal 2015 è Responsabile dell'Unità di Ricerca di Neuroscienze Molecolari e dal 2010 è Direttore del Laboratorio di Neuroscienze Molecolari. Dal 2019 al 2022 è stato Coordinatore della Ricerca della Facoltà Dipartimentale di Scienze e Tecnologie per l'Uomo e l'Ambiente.
Biografia
Marcello D’Amelio,
Ph.D. in Neuroscience
M.Sc. in Clinical Experimentation
Curriculum
Current position
• Full Professor of Human Physiology, Medical School University Campus-Biomedico, Rome, (I);
• Research Coordinator of the Department of Medicine and Surgery
• Group leader at the Centro Europeo Ricerca sul Cervello (CERC) – I.R.C.C.S Santa Lucia Foundation IRCCS, Rome (I);
• Member of Scientific Committee, Centre of Molecular Nutrition for Sport (www.cmnsport.com);
Current Research Interests
Analysis of synaptic and neuronal degeneration in rodent models of Alzheimer’s Disease and other neurological disorders; Apoptosis and Autophagy applied to neuroscience field.
Professional Society Membership
• Since 2003 Member of the Italian Society of Biochemistry and Molecular Biology
• Since 2004 Member of the Society of Neuroscience
• Since 2010 Member of the Italian Society of Pharmacology
Editorial activity
• Associate Editor of Translational Research in Dementia;
• Member of Editorial Board of Neuromolecular Medicine, Scientific Reports;
• Guest Editor of Current Pharmaceutical Design
• Referee of Journal of Alzheimer’s disease, NeuroMolecular Medicine, Journal of Neuroscience Research, World Journal of Pharmacology, European Journal of Neurodegenerative diseases and Cell Death and Disease.
Grants
- Modulating synaptic neurotransmission to reactivate the immune reaction against brain tumors. MUR - PRIN 2020 – Role: Unit’s PI
- Dopamine loss and neuroinflammation in Alzheimer's Disease: two sides of the same coin?” Alzheimer Association, USA - AARG-21-851219; Role: Coordinator
- New natural neuroprotective molecules to slow the progression of AD” within the CurAlz Project POR A0375-2020-36665; Role: Co-Pi
- Beyond Amyloid Hypothesis: a novel approach to fight Alzheimer’s Disease, Fondazione Roma, Role: Coordinator
- Pharmacological and non-pharmacological recruitment of dopaminergic mesolimbic pathway in early AD; Farmindustria, Italy: Role: Coordinator
- Targeting dopamine neuronal loss in a model of Alzheimer’s Disease – Alzheimer Association, USA - AARG-18-566270, Role: Coordinator
- Ventral Tegmental Area dopaminergic midbrain: new therapeutic target in early Alzheimer’s Disease – Italian Ministry of Health RF-2028-1236552; Role: Coordinator
Patents
Autophagy enhancing compounds, peptides and peptidomimetic compounds for use in the treatment of neuronal diseases - PCT Patent 2012/076555.
PUBBLICAZIONI
Please check the following link:
https://orcid.org/0000-0001-6526-1832